Bluepharma Indústria Farmacêutica reinforces capital, through an investment of 30 million euros from C2 Capital, which now holds a minority stake in the company's capital

Bluepharma and C2 Capital establish a partnership, with a view to providing a financial boost, which will allow the company's strategic projects planned for the next decade to continue. The objective of the investment of 30 million euros is to reinforce the Research and Development strategy and, consequently, industrial capacity building of the pharmaceutical multinational, based in Coimbra.

This investment will also allow the company to continue with more solidity, the development of the projects “Coimbra Life Sciences Park” and CiNTech, this last one within the scope of the PRR (Resilience and Recovery Plan), which aims to promote the creation and training of the first Hub Technology entirely dedicated to complex injectable medicines in Portugal.

Paulo Barradas Rebelo, President of Bluepharma, highlights, “this investment strengthens the confidence with which we face the future, as well as Bluepharma's third decade, which will be marked by profound changes that will transform the company's profile. Thus, from a company that supported itself on a portfolio of generic medicines for outpatients, in the future it will have increasing importance in the area of oncology medicines and in cutting-edge therapeutic strategies, such as advanced therapies focusing on the hospital market with products that are increasingly more sophisticated and differentiated.”

André Oliveira, partner and administrator of C2 Capital, says, “C2's strategy involves investing in competitive companies, with permanent capacity to develop R&D activities and with highly qualified management teams. In this sense, it is with great satisfaction that today we join Bluepharma and its Acelera 2030 project”.

Bluepharma thus takes another step towards differentiation, contributing not only to the country's development but also to the urgent reindustrialization of Europe.

About C2 Capital Partners

C2 Capital Partners is a private equity company with more than 14 years of history and with a special focus on the Portuguese market. C2 has raised more than 800 million euros in capital, from hundreds of investors, with different investment profiles, with a total of 12 funds under management. Today, C2 Capital Partners has a portfolio with investments in 42 companies of different sizes and different sectors.